Bio-Rad Laboratories BIO Return on equity

Return on equity at other companies

AbbottABT

10.7%-20.4pp

Becton, Dickinson and CompanyBDX

3.8%-2.4pp

Thermo Fisher ScientificTMO

13.5%+0.1pp

DanaherDHR

7.6%+1.0pp

MaxCyteMXCT

-21.3%+2.0pp

Quanterix CorporationQTRX

-34.8%-122pp

FAQ

What is Bio-Rad Laboratories's return on equity?

Bio-Rad Laboratories (BIO) reported return on equity of 2.5% in Q1 2026.

How has Bio-Rad Laboratories's return on equity changed year-over-year?

Bio-Rad Laboratories's return on equity increased by 109.1% year-over-year, from -27.5% to 2.5%.

What is the long-term trend for Bio-Rad Laboratories's return on equity?

Over 5 years (2020 to 2025), Bio-Rad Laboratories's return on equity has grown at a -25.9% compound annual growth rate (CAGR), from 48.7% to 10.8%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.